Loading…

Browse All Grants

20,252 grants found

Filters
Reset

Showing 961980 of 20,252 grants

Active TRAINING, INDIVIDUAL
Dissecting the Functional Consequences of Mutations in ZFP36L2 on Tumor Progression and Inflammation in the Tumor Immune Microenvironment of Colorectal Cancer
NATIONAL CANCER INSTITUTE Weill Medical Coll of Cornell Univ United States 2024 – 2028

PROJECT SUMMARY/ABSTRACT Colorectal cancer (CRC) is a devastating disease with no effective therapeutic options for patients suffering from advanced metastasis. Immune checkpoint i...

$539.7K
USD
Active NON-SBIR/STTR RPGS
ProAgio in Pancreatic Cancer
NATIONAL CANCER INSTITUTE University of Alabama At Birmingham United States 2024 – 2029

SUMMARY/ABSTRACT Cancer associated fibroblasts and pancreatic stellate cells (PSC/CAF) and abnormal tumor blood vessels are two major factors that contribute to treatment failure....

$5.9M
USD
Active TRAINING, INDIVIDUAL
Understanding the role of altered lipid metabolism in CD8 T cell exhaustion within the tumor microenvironment
NATIONAL CANCER INSTITUTE University of Pittsburgh At Pittsburgh United States 2024 – 2027

PROJECT SUMMARY/ABSTRACT The recent successes of checkpoint blockade therapies have highlighted the potential of immunotherapy for cancer treatment. Still, only about 30% of treatm...

$489.7K
USD
Active TRAINING, INDIVIDUAL
Endothelial Cell Cycle Control to Normalize the Tumor Vasculature
NATIONAL CANCER INSTITUTE University of Virginia United States 2024 – 2027

Tumor blood vessels are dysfunctional and irregular, impairing immune cell infiltration and drug delivery and creating areas of severe hypoxia that select for aggressive cancer cel...

$382K
USD
Active NON-SBIR/STTR RPGS
Enhanced radiotherapy for pediatric glioma via synthetic lethal vulnerabilities
NATIONAL CANCER INSTITUTE Dana-Farber Cancer Inst United States 2024 – 2029

Project Summary Diffuse midline gliomas (DMG) are the most common malignant brain tumors of children. They are surgically inaccessible and refractive to chemotherapy. The prevalent...

$7.67M
USD
Active TRAINING, INDIVIDUAL
Exploring the molecular mechanisms controlling CDK7i sensitivity in pancreas cancer
NATIONAL CANCER INSTITUTE Fred Hutchinson Cancer Center United States 2024 – 2026

PROJECT SUMMARY/ABSTRACT Pancreatic ductal adenocarcinoma (PDA) is projected to be the second leading cause of cancer deaths in the US by 2030. With no cost-effective screening or...

$742.8K
USD
Active NON-SBIR/STTR RPGS
IL-6 and IL-6R genetic polymorphisms in immune-related adverse events caused by cancer immunotherapy
NATIONAL CANCER INSTITUTE University of Colorado Denver United States 2024 – 2026

SUMMARY The achievements obtained with different types of cancer immunotherapy are clear, with durable long-term survival in some cases. The most frequently used immunotherapeutic...

$4.01M
USD
Active TRAINING, INDIVIDUAL
Structural and mechanistic investigation into EWS::FLI1 disruption of EWS function in transcription and DNA repair
NATIONAL CANCER INSTITUTE University of Texas Hlth Science Center United States 2024 – 2027

PROJECT SUMMARY Ewing sarcoma is a pediatric bone and soft tissue cancer that results from chromosomal translocation, most commonly t(11;22)(q24;q12), which fuses the low-complexit...

$383.6K
USD
Active TRAINING, INDIVIDUAL
Dissecting the Role of TRPV1 in Triple-Negative Breast Cancer Innervation
NATIONAL CANCER INSTITUTE Tufts University Boston United States 2024 – 2028

PROJECT SUMMARY: Breast cancer is the most common form of malignancy in women, accounting for almost one in three new female cancer diagnoses each year. The primary cause of breast...

$445.7K
USD
Active TRAINING, INDIVIDUAL
Brain microenviornment-dependent lineage plasticity drives adaptation to targeted therapy in malignant gliomas
NATIONAL CANCER INSTITUTE University of California Los Angeles United States 2024 – 2028

PROJECT SUMMARY/ABSTRACT Malignant gliomas are the most common primary adult brain cancer, affecting over 20,000 Americans each year. While molecularly targeted therapies have demo...

$413.3K
USD
Active NON-SBIR/STTR RPGS
Targeting tumoral Lactobacillus iners to improve outcomes in cervical cancers
NATIONAL CANCER INSTITUTE University of Tx Md Anderson Can Ctr United States 2024 – 2029

Cervical cancer remains the second most common cancer killer of women worldwide, with an annual incidence of more than 600,000 and an annual death rate of 300,000. Further, cervica...

$6.61M
USD
Active NON-SBIR/STTR RPGS
Identifying cell surface targets for innovative immunotherapy of Multiple Myeloma
NATIONAL CANCER INSTITUTE H. Lee Moffitt Cancer Ctr & Res Inst United States 2024 – 2029

Project Summary Multiple myeloma (MM) is an incurable malignancy of mature plasma cells accounting for 1.8% of new cancer cases annually, and 10% of hematological malignancies. Imm...

$5.28M
USD
Active NON-SBIR/STTR RPGS
Development of a New Multiplexed Imaging Strategy for Immunoprofiling using Raman-Active Nanoparticles
NATIONAL CANCER INSTITUTE University of Southern California United States 2024 – 2029

Project Summary The -omics era has made it possible to identify several molecular markers involved in predicting survival and response to therapies. We currently lack an easy way t...

$6.44M
USD
Active TRAINING, INDIVIDUAL
Elucidating Glutamine Metabolism in Breast to Bone Metastasis
NATIONAL CANCER INSTITUTE Vanderbilt University United States 2024 – 2027

Project Summary Several aggressive types of breast cancer (BCa) are nutritionally reliant on glutamine metabolism, and glutamine uptake has been shown to be enhanced in BCa bone-ho...

$343.7K
USD
Active NON-SBIR/STTR RPGS
Defining Tumor Microenvironmental Mediators of Prostate Cancer Metastasis and Therapy Resistance
NATIONAL CANCER INSTITUTE Vanderbilt University Medical Center United States 2024 – 2029

Metastatic prostate cancer remains incurable and inevitably progresses to lethal disease despite expanding treatment options.Standard of care includes therapies targeting the andro...

$5.76M
USD
Active TRAINING, INDIVIDUAL
Engineering CD4+ T cells to develop a novel immunotherapy for pancreatic cancer
NATIONAL CANCER INSTITUTE Emory University United States 2024 – 2027

Project Summary: Pancreatic ductal adenocarcinoma (PDAC) is a solid tumor with limited treatment options and a dismal five-year survival rate of only 12%, necessitating the develop...

$489.7K
USD
Active TRAINING, INDIVIDUAL
Development and characterization of self-amplifying RNA Lipid Nanoparticles for potent and multiplex gene expression in solid tumors
NATIONAL CANCER INSTITUTE Boston University (Charles River Campus United States 2024 – 2027

Project Summary Specific Aims Solid tumors account for nearly 90% of adult cancers and are challenging to eliminate. Surgery and adjuvant therapy (e.g., radiation, chemotherapy, an...

$406.7K
USD
Active TRAINING, INDIVIDUAL
Engineering Focused Ultrasound-Mediated Gene Delivery Platforms for Glioblastoma
NATIONAL CANCER INSTITUTE University of Virginia United States 2024 – 2026

Abstract Glioblastoma multiforme (GBM) is an aggressive primary brain tumor with a median survival of approximately 15 months. Currently, the standard of care therapy includes rese...

$407.7K
USD
Completed TRAINING, INDIVIDUAL
THE FUNCTION OF CASPASE-8 IN CANCER, ANTI-CANCER IMMUNITY, AND CAR-T CELL FUNCTION
NATIONAL CANCER INSTITUTE St. Jude Children'S Research Hospital United States 2024 – 2026

Project Summary/Abstract: Caspase-8 is the primary protein that drives the extrinsic apoptotic pathway, and is frequently mutated, contains polymorphisms, or downregulated in vario...

$767.6K
USD
Completed OTHER RESEARCH-RELATED
Dynamics and Encoding in Signal Transduction
NATIONAL CANCER INSTITUTE Federation of Amer Soc for Exper Biology United States 2024 – 2025

PROJECT SUMMARY Cell communication research is a growing field that is complimentary to, but distinct from, traditional signal trans- duction fields. This emerging field emphasizes...

$152.5K
USD